COVID-19 Resources
These COVID-19-related resources have been gathered in an effort to support healthcare providers, and are not intended to provide medical advice or to substitute for the judgment of healthcare professionals in the care of their patients.
Have resource recommendations, or did you find outdated information? Let us know.
- NASPAG Talking Points for Clinicians to Discuss Pfizer-BioNTech Vaccine with Parents and Adolescent Patients
- FWGBD Archived Webinar on Vaccine-Induced Thrombotic Thrombocytopenia: What We Know & Don’t Know
- Preventing Thrombosis in COVID-19: Anticoagulation Algorithm (Blog post by Dr. Stephan Moll, from Clot Connect)
- ASH Archived Webinar on Triage and Treatment of Patients with Potential Vaccine-Induced Thrombotic Thrombocytopenia Post J&J COVID-19 Vaccination
- Data Summaries from ASH COVID-19 Registry
- General Principles of COVID-19 Vaccinations for Immunocompromised Patients
- ISTH Guidance on Diagnosis & Treatment of Vaccine-Induced Immune Thrombocytopenia
- ASH Guidance on Vaccine-Induced Immune Thrombocytopenia (also called Thrombosis with Thrombocytopenia Syndrome)
- Guidance and Resources from the Anticoagulation Forum on the Treatment of Vaccine-Induced Immune Thrombocytopenia
- COVID-19 Vaccine and Blood Clots
- National Hemophilia Foundation’s FAQs on COVID-19 Vaccine and Blood Disorders
- Comments from Dr. Len Valentino (NHF) on COVID-19 Vaccine and Blood and Bleeding Disorders
- ASH’s FAQs on COVID-19 Vaccines
- CDC’s Background Primer on COVID-19 Vaccines
- CIBD: COVID-19 Vaccine While on Immunosuppressants
- ITP InsightsSM Patient Education Webinar Series Program: COVID-19 & ITP: Viruses and Vaccines and How They Can Affect Platelets
- COVID-19 and ITP Research Survey (part of ITP Registry)
- Publication: Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection
- Latest Resources from the Anti-Coagulation Forum: Focused on the treatment and prevention of thrombosis and management of coagulopathy
- Elsevier Resource Hub on COVID-19 Treatment: Focused on ICU treatment
- Latest COVID-19 Resources from ASH Publications
- Blood: Latest COVID-19 Articles
- Blood Advances: Latest COVID-19 Articles
- ASH Clinical News: COVID-19 News
- The Hematologist: COVID-19 Articles and Podcast
- ASH Guidelines for Treatment of COVID-19 and ITP
- Global Resources for ITP Patients Infected with COVID-19, from the International ITP Alliance
- Facts over Fear: COVID-19 & ITP Town Hall from PDSA
- ASH 2021 Guidelines on the Use of Anticoagulation for Thromboprophylaxis for Treatment of Patients with COVID-19
- COVID-19 Guidance from Hemophilia Foundation of America
- Guidelines and Resources from World Hemophilia Federation
- Hemophilia and COVID-19: Resource Library (Wiley Online Library)
- Frequently Asked Questions about COVID-19 from the National Hemophilia Foundation (for patients)
- Patient Resources on Health, Resource Availability, and Financial Concerns from the National Hemophilia Foundation (for patients)
- Resources from the US Centers for Disease Control and Prevention (CDC)
- Resources from the World Health Organization (WHO)
- Johns Hopkins University’s COVID-19 Tracker Map
- Resources from the American Medical Association (AMA)
- Resources from the American Association of Blood Banks (ABB) including information on convalescent plasma treatment
- Resources from the American College of Physicians (ACP)
- Resources from the American College of Cardiology (ACC)
- Resources from the American Academy of Pediatrics (AAP) on COVID-19, including MIS-C